Replimune Group, Inc. (REPL) Earnings
NASDAQ·Healthcare·Biotechnology
$14.57
+11.88%
Mkt Cap $1.23B
EPS — Estimate vs Actual
Mkt Cap
$1.23B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.58
NASDAQ·Healthcare·Biotechnology
$14.57
+11.88%
Mkt Cap $1.23B
Mkt Cap
$1.23B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.58